Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Quanterix Corp (QTRX)

Quanterix Corp (QTRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 359,675
  • Shares Outstanding, K 46,711
  • Annual Sales, $ 137,420 K
  • Annual Income, $ -38,530 K
  • EBIT $ -115 M
  • EBITDA $ -108 M
  • 60-Month Beta 1.01
  • Price/Sales 2.54
  • Price/Cash Flow N/A
  • Price/Book 1.02

Options Overview Details

View History
  • Implied Volatility 185.57% (-25.88%)
  • Historical Volatility 65.52%
  • IV Percentile 87%
  • IV Rank 43.62%
  • IV High 355.53% on 11/11/25
  • IV Low 54.07% on 02/14/25
  • Expected Move (DTE 14) 1.19 (15.45%)
  • Put/Call Vol Ratio 0.02
  • Today's Volume 465
  • Volume Avg (30-Day) 117
  • Put/Call OI Ratio 0.02
  • Today's Open Interest 3,392
  • Open Int (30-Day) 3,703
  • Expected Range 6.51 to 8.89

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.27
  • Number of Estimates 1
  • High Estimate -0.27
  • Low Estimate -0.27
  • Prior Year -0.30
  • Growth Rate Est. (year over year) +10.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.50 +71.11%
on 11/11/25
7.89 -2.35%
on 12/04/25
+2.49 (+47.79%)
since 11/04/25
3-Month
4.25 +81.18%
on 09/09/25
7.89 -2.35%
on 12/04/25
+3.38 (+78.24%)
since 09/04/25
52-Week
4.05 +90.12%
on 05/14/25
12.94 -40.49%
on 12/05/24
-5.07 (-39.70%)
since 12/04/24

Most Recent Stories

More News
Quanterix Announces Board and Leadership Changes to Support Next Stage of Growth

Appoints Garret Hampton and Alan Sachs to the Board Appoints William Donnelly as Executive Chair of the Board and Jeffrey Elliott as Lead Independent Director

IDYA : 36.01 (+4.86%)
TROW : 105.79 (+0.70%)
EXAS : 101.13 (-0.12%)
ILMN : 128.03 (+0.06%)
TMO : 575.24 (-0.90%)
SERA : 2.98 (-3.56%)
IR : 79.99 (+0.30%)
MTD : 1,422.81 (-0.84%)
QTRX : 7.70 (+2.94%)
LIFE : 1.9000 (+2.70%)
Quanterix Announces Landmark Study Demonstrating Dual GFAP/NfL Blood Test Approach for Personalized Multiple Sclerosis Monitoring

Publication in the journal ‘Brain’ confirms complementary roles of the biomarkers for predicting relapse and chronic disability progression in multiple sclerosis (MS) ...

QTRX : 7.70 (+2.94%)
Quanterix Releases Financial Results for the Third Quarter of 2025

Quanterix Corporation (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced financial results for the...

QTRX : 7.70 (+2.94%)
Quanterix To Report Third Quarter 2025 Financial Results on November 10, 2025

Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that it will host a conference call on Monday, November...

QTRX : 7.70 (+2.94%)
Quanterix Approves Key Governance Changes at Annual Meeting

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Quanterix...

QTRX : 7.70 (+2.94%)
Quanterix Accelerator Laboratory Awarded Rigorous New York State Clinical Laboratory Permit

Permit approval enables expanded research capabilities and underscores commitment to accuracy, reliability, and scientific excellence

QTRX : 7.70 (+2.94%)
Quanterix to Present at the Canaccord Genuity 45th Annual Growth Conference

Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that its executive leadership team will present at the Canaccord...

QTRX : 7.70 (+2.94%)
Quanterix Releases Financial Results for the Second Quarter of 2025

Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detection, today announced financial results for the second quarter ended...

QTRX : 7.70 (+2.94%)
Quanterix To Report Second Quarter 2025 Financial Results on August 7, 2025

Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that it will host a conference call on Thursday, August...

QTRX : 7.70 (+2.94%)
Quanterix Announces Cooperation Agreement with Kent Lake Capital

Company and Kent Lake Capital Agree to Identify New Independent Board Member Company will Seek Shareholder Approval to De-Classify its Board...

QTRX : 7.70 (+2.94%)

Business Summary

Quanterix Corporation is a developer of tools in high definition diagnostics. The Company focuses on research and diagnostics for brain injuries, heart disease, cancer and other diseases with its technology. It offers Simoa consumables, which include Simoa Discs, Simoa Cuvettes, Simoa Sealing Oil, Simoa...

See More

Key Turning Points

3rd Resistance Point 8.70
2nd Resistance Point 8.29
1st Resistance Point 7.99
Last Price 7.70
1st Support Level 7.29
2nd Support Level 6.89
3rd Support Level 6.59

See More

52-Week High 12.94
Fibonacci 61.8% 9.54
Fibonacci 50% 8.49
Last Price 7.70
Fibonacci 38.2% 7.45
52-Week Low 4.05

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar